ArticlePloS one2013

Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.

Chiara Sassoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.